Related Experiment Video
Updated: Jun 16, 2026
Microglia as a Surrogate Biosensor to Determine Nanoparticle Neurotoxicity
Published on: October 25, 2016
Nanomaterials as Microglia Modulators in the Treatment of Central Nervous System Disorders
Matteo Battaglini1, Attilio Marino1, Margherita Montorsi1,2
1Istituto Italiano di Tecnologia, Smart Bio-Interfaces, Viale Rinaldo Piaggio 34, Pontedera, 56025, Italy.
Abstract:
Microglia play a pivotal role in the central nervous system (CNS) homeostasis, acting as housekeepers and defenders of the surrounding environment. These cells can elicit their functions by shifting into two main phenotypes: pro-inflammatory classical phenotype, M1, and anti-inflammatory alternative phenotype, M2. Despite their pivotal role in CNS homeostasis, microglia phenotypes can influence the development and progression of several CNS disorders such as Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, multiple sclerosis, ischemic stroke, traumatic brain injuries, and even brain cancer. It is thus clear that the possibility of modulating microglia activation has gained attention as a therapeutic tool against many CNS pathologies. Nanomaterials are an unprecedented tool for manipulating microglia responses, in particular, to specifically target microglia and elicit an in situ immunomodulation activity. This review focuses the discussion on two main aspects: analyzing the possibility of using nanomaterials to stimulate a pro-inflammatory response of microglia against brain cancer and introducing nanostructures able to foster an anti-inflammatory response for treating neurodegenerative disorders. The final aim is to stimulate the analysis of the development of new microglia nano-immunomodulators, paving the way for innovative and effective therapeutic approaches for the treatment of CNS disorders.
Insights
Nanomaterials can modulate microglia, the brain
Area of Science:
- Neuroscience and Immunology
- Biomaterials Science
Background:
- Microglia are crucial for central nervous system (CNS) homeostasis, with M1 (pro-inflammatory) and M2 (anti-inflammatory) phenotypes.
- Dysregulated microglia phenotypes contribute to CNS disorders like Alzheimer's, Parkinson's, and brain cancer.
- Targeting microglia activation is a promising therapeutic strategy for CNS pathologies.
Purpose of the Study:
- To explore nanomaterials for modulating microglia responses in CNS disorders.
- To discuss using nanomaterials to stimulate pro-inflammatory microglia for brain cancer.
- To introduce nanostructures for anti-inflammatory microglia responses in neurodegenerative diseases.
Main Methods:
- Review of existing literature on nanomaterial applications in microglia modulation.
- Analysis of nanomaterial strategies for targeting M1 and M2 microglia phenotypes.
- Focus on in situ immunomodulation via nanomaterial-microglia interactions.
Main Results:
- Nanomaterials offer a novel approach to specifically target and manipulate microglia.
- Potential for nanomaterials to induce pro-inflammatory microglia against brain tumors.
- Potential for nanostructures to promote anti-inflammatory microglia for neuroprotection.
Conclusions:
- Nanomaterial-based microglia modulation holds significant therapeutic potential for CNS disorders.
- Development of novel microglia nano-immunomodulators is crucial for effective treatments.
- This approach paves the way for innovative therapies for neurodegenerative diseases and brain cancer.
